Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS1 | Q07889 | 2/20 | 0.42 |
| ▸ | MPO | P05164 | 10/20 | 0.34 |
| ▸ | ICMT | O60725 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23721995 | 0.99 | SOS1 (0.41) | SOS1MPOICMTMAPTMEN1 | |
| SCHEMBL23745514 | 0.94 | SOS1 (0.48) | SOS1MPOICMTMAPTMEN1 | |
| SCHEMBL23745678 | 0.93 | MPO (0.37) | SOS1MPOICMTMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL23722018 | 0.92 | MPO (0.36) | SOS1MPOICMTMAPTMEN1 | |
| SCHEMBL23745691 | 0.92 | CNR1 (0.38) | SOS1MPOICMTMAPTMEN1 | |
| SCHEMBL23745690 | 0.92 | CNR1 (0.38) | SOS1MPOICMTMAPTMEN1 | |
| SCHEMBL23745852 | 0.92 | CNR1 (0.38) | SOS1MPOICMTMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL23721956 | 0.91 | CNR1 (0.37) | SOS1MPOICMTMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL23722162 | 0.91 | CNR1 (0.37) | SOS1MPOICMTMAPTMEN1 | |
| SCHEMBL23745636 | 0.90 | SOS1 (0.48) | SOS1MPOICMTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | FDPS, FPR1, F12 | SOS1 2902/4885MPO 17/4885ICMT 345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.